Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETHEMA-LAM99: AML Treatment in Elderly
NCT00464217Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Oct 1998
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of idarubicin in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Oct 1998; status: completed.
02
Drugs
idarubicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00464217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464217.